AKF Then and Now: A Legacy of Caring
Helping Patients in Need
The American Kidney Fund was founded in 1971 out of concern for a single individual who had been bankrupted by the costs associated with treating kidney failure. In ourfirst year, weprovided financial assistance to 79 patients who would not have otherwise been able to pay for life-saving dialysis treatments.
Today, AKF has grown into the nation’s leading provider of charitable assistance to dialysis patients. In 2014, we helped more than 84,000 people—1 out of every 5 dialysis patients in the United States—pay for health insurance premiums and other treatment-related expenses. Since our founding, we have provided financial assistance to more than 1 million patients.
Increasing Awareness of a Silent Killer
In 1980, we began a public education outreach program to promote our new toll-free patient assistance and kidney information line.
Today, millions of people nationwide benefit from our efforts to raise awareness of kidney disease through health education and prevention efforts. Extensive online health education materials and a toll-free HelpLine (866.300.2900) provide information to people nationwide who are at risk for kidney disease.
Supporting Clinical Research
In 2014, we named Dr. John Stanifer, a research fellow at Duke University, as the 2015-2016 American Kidney Fund–Amgen Clinical Scientist in Nephrology fellow and Dr. Susan Wong, a research fellow at the University of Washington Medical Center, as the 2015-2016 American Kidney Fund–Sanofi Clinical Scientist in Nephrology fellow.
Advancing Professional Education
In the late 1970s, we began sponsoring professional meetings that explored important developments in the treatment of kidney disease, working with leading hospitals and nephrologists.
Today, we provide continuing education to thousands of renal and primary care professionals each year through our online courses. These professional education programs cover a wide range of topics related to advances in kidney disease and treatment, prevention, and the importance of early identification and intervention—all with a focus on improving patient quality of life.
Advocating for Patients
From our earliest days, we have been an active advocate for public policy that ensures access to high quality care for kidney patients and supports research and prevention efforts.
Today, we are actively engaged with the Congressional Kidney Caucus and others representing groups at risk for kidney disease, helping build understanding of the disease, its causes and how it can be prevented. Our Advocacy Network informs and motivates patients, family, friends and caregivers to speak out and raise awareness in the fight against kidney disease. The network’s more than 4,000 advocates from all 50 states and the District of Columbia engage policymakers on issues relating to kidney disease and patient care.
Reaching Out to Communities at Risk
Recognizing the disproportionate impact of kidney disease on African Americans, in 1996 we launched a health screening program, enlisting churches and other organizations in a broad education and early intervention effort.
Today, we hold free health screening events in cities around the country, with an emphasis on reaching populations most at risk for kidney disease: people with diabetes, high blood pressure or a family history of kidney disease; those over age 60; and anyone who is African American, Hispanic, Asian American or Native American. Thousands of people are screened each year, and around 25 percent are found to have risk factors for kidney disease. Over the past 10 years, we have screened more than 100,000 people.